QUALCOMM, Inc. vs Sana Biotechnology Inc — how do they compare? QUALCOMM, Inc. trades at $177.77 (market cap $182.87B), while Sana Biotechnology Inc trades at $3.13 (market cap $879.40M). The key difference: QUALCOMM, Inc. is far larger — about 207.9× Sana Biotechnology Inc's market cap, and QUALCOMM, Inc. pays a 2.12% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| QCOM | SANA | |
|---|---|---|
Market Cap | $182.87B | $879.40M |
Sector | Technology | Health |
52-Week High | $251.10 | $5.92 |
52-Week Low | $124.07 | $2.68 |
Enterprise Value | $188.34B | $853.59M |
Dividend Yield | 2.12% | — |
Signals from Pluang's Aura AI — not financial advice
Qualcomm (QCOM) trades at $175.55, up 3.07% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 22.31% net income margin and 29.27% ROE, though margins face pressure. Analyst consensus is a $228.22 price target with 42.65% buy ratings. Recent news highlights AI and data center growth initiatives amid smartphone market challenges.
The outlook balances AI diversification potential against near-term margin and competitive risks. Investment opportunity lies in data center revenue growth and market share gains, but risks include Nvidia's PC chip entry and handset demand softness. Wall Street remains cautiously optimistic with a hold-heavy rating distribution.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →